AstraZeneca Remains On Track To Submit Vaccine Data To Regulators Before Year Ends, CEO Says

Financial Times: AstraZeneca ‘still on track’ to submit Covid vaccine data before end of year
“AstraZeneca is still on target to submit data on its Covid-19 vaccine candidate to regulators before the end of the year, providing it can restart trials halted temporarily after a participant fell ill, the company’s chief executive has said…” (Neville, 9/10).

Additional coverage on efforts to develop a SARS-CoV-2 vaccine is available from POLITICO Magazine, Reuters (2), and TIME.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.